UBS Group started coverage on shares of Natera (NASDAQ:NTRA – Get Rating) in a research note issued to investors on Friday, The Fly reports. The brokerage issued a buy rating and a $76.00 price target on the medical research company’s stock. Several other analysts have also recently commented on NTRA. Raymond James boosted their price […]
Natera, Inc. (NASDAQ:NTRA – Get Rating) CEO Steven Leonard Chapman sold 885 shares of the firm’s stock in a transaction that occurred on Monday, April 24th. The stock was sold at an average price of $54.98, for a total transaction of $48,657.30. Following the sale, the chief executive officer now directly owns 212,405 shares of […]
Natera, Inc. (NASDAQ:NTRA – Get Rating) CEO Steven Leonard Chapman sold 1,689 shares of the firm’s stock in a transaction that occurred on Friday, April 21st. The stock was sold at an average price of $54.27, for a total value of $91,662.03. Following the completion of the sale, the chief executive officer now owns 211,516 […]
Natera, Inc. (NASDAQ:NTRA – Get Rating) CEO Steven Leonard Chapman sold 2,612 shares of the company’s stock in a transaction that occurred on Tuesday, March 28th. The shares were sold at an average price of $55.13, for a total value of $143,999.56. Following the completion of the sale, the chief executive officer now owns 212,390 […]
Natera, Inc. (NASDAQ:NTRA – Get Rating) CEO Steven Leonard Chapman sold 4,736 shares of the company’s stock in a transaction on Wednesday, March 22nd. The stock was sold at an average price of $56.32, for a total value of $266,731.52. Following the transaction, the chief executive officer now directly owns 209,819 shares in the company, […]